Improvement of Neurocognitive Function in Responders to an Antiviral Therapy for Chronic Hepatitis C
Hepatology2013Vol. 58(2), pp. 497–504
Citations Over TimeTop 11% of 2013 papers
Michael R. Kraus, Arne Schäfer, G Teuber, H. Porst, Kathrin Sprinzl, Sven Wollschläger, Christian Keicher, Michael Scheurlen
Abstract
Successful eradication of HCV leads to a significant improvement of relevant aspects of attentional and neurocognitive performance, indicating that the neurocognitive impairment caused by chronic HCV infection is potentially reversible. This therefore suggests an added therapeutic benefit of antiviral treatment in HCV infection. Improvement of neurocognitive function may be an additional treatment indication in patients with HCV. (HEPATOLOGY 2013;58:497-504).
Related Papers
- → Corrigendum to “Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy” [J Hepatol 2011;54:195–200](2016)
- Research progress of antiviral therapy on chronic hepatitis C(2013)
- [Current issues in antiviral therapy of chronic hepatitis B and C].(2010)
- [A report from the second symposium on the hots and difficult points during antiviral therapy for chronic hepatitis B].(2011)
- → Pharmaco-economical analysis and its applying to economical efficacy evaluation of different antiviral therapy schemes of chronic hepatitis c(2006)